arkiv - Confirmed case of measles in Oslo
Measles has been confirmed in an unvaccinated adult in Oslo. The patient was infected while travelling outside Europe, and is now in hospital.
The Chief Medical Officer in Oslo has been notified and work is ongoing to identify close contacts, so that these can be offered the vaccine if they are unvaccinated. The patient was contagious during a flight to Norway and the airline has been contacted to inform passengers. Since it will take some time to contact all the passengers with information about potential exposure to the measles virus, here is the information about the two flights from Turkish Airlines:
- Tel Aviv – Istanbul, departed Friday 6th March at 9:50 a.m., TK 785
- Istanbul – Oslo, departed Friday 6th March at 2.15 p.m., TK 1753
The Norwegian Institute of Public Health has notified the international networks that register and monitor infectious diseases.
Measles is a highly contagious disease that, in rare cases, can have serious consequences. Most people in Norway are fully vaccinated and are protected against the disease.
Unvaccinated people or individuals with uncertain vaccination status are recommended to take the MMR vaccine. For unvaccinated infants, unvaccinated pregnant women and severely immunocompromised individuals, immunoglobulin can provide some protection against severe illness when given within 5 or 6 days after infection. The treating doctor should consult the vaccine department at the NIPH in such cases.
People born before 1960 are assumed to have undergone measles. People aged over 15 months who have followed the childhood immunisation programme are protected. To check your vaccination status or be vaccinated, contact the public health clinic, infection disease control office or a centre for travel vaccination.
People who were vaccinated in Norway can check their immunisation status via the "My Vaccines" service, but records may be lacking for people born before 1995.
“This is a reminder that everyone should be vaccinated against measles,” said Dr. Trude Arnesen from the Department of Infectious Disease Epidemiology at the Norwegian Institute of Public Health.